Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Board/Management Information 2026

Mar 30, 2026

62573_rns_2026-03-30_554014a2-4ffa-48b8-a1d4-0c836a3357a8.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

March 30, 2026

The Manager, Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: PANACEABIO

BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349

Sub: Intimation of resignation of CA Rajesh Jain as Non-Executive Independent Director

Ref.: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), we would like to inform you that CA Rajesh Jain* (DIN: 10619014), non-executive independent director of the Company and its material wholly owned subsidiary, Panacea Biotec Pharma Limited ("PBPL") vide his e-mails dated March 30, 2026, has tendered the resignation as Independent Director of the Company and PBPL, with effect from close of business hours on June 30, 2026.

His decision to resign is driven by existing professional commitments and the increasing time demands arising from the evolving regulatory and corporate governance requirements, resulting in inability to devote adequate time, attention, and diligence required for the role. Accordingly,stepping down is considered appropriate by him in order to uphold the highest standards of corporate governance.

It is further informed that there is no other material reason for the resignation other than the reason mentioned above.

Consequently, he shall also cease to be the Chairman / member of the Committees of the Board of Directors of the Company and PBPL w.e.f. close of business hours on June 30, 2026, or such other earlier date as may be decided by the Board in due course of time.

The Board of Directors and the Management of the Company and PBPL express deep appreciation and gratitude to CA Rajesh Jain for his contribution and guidance towards the business growth of the Company, during his association with the Company and PBPL.

The details required to be disclosed under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. SEBI/HO/CFD/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed herewith as Annexure – A and the copies of e-mail vide which the director has tendered the resignation are enclosed herewith as Annexure - B.

This is for your kind information and record please.

Thanking you, Sincerely yours, For Panacea Biotec Limited

JAIN

ANKIT Digitally signed by ANKIT JAIN Date: 2026.03.30 16:49:22 +05'30'

Ankit Jain General Manager – Legal & Company Secretary

Note: CA Rajesh Jain, Independent Director shares same name as of our Chairman and Managing Director, Dr. Rajesh Jain.

Panacea Biotec Limited (CIN: L33117PB1984PLC022350)

Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27 Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]

Annexure – A

Details required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with SEBI Master Circular No. SEBI/HO/CFD/CFD/PoD2/CIR/P/0155 dated November 11, 2024

# Particulars Description
1. Reason for change viz. appointment,
reappointment,
resignation,
removal,
death
or otherwise
Resignation of CA
Rajesh Jain (DIN: 10619014) as an
Independent Director of the Company and Company's
material wholly owned subsidiary, Panacea Biotec
Pharma Ltd. due to existing professional commitments
and the increasing time demands arising from the
evolving
regulatory
and
corporate
governance
requirements, resulting in inability to devote adequate
time, attention, and diligence required for the role.
2. Date of appointment / re-appointment /
cessation (as applicable) & term of
appointment/re-
appointment
Close of business hours on June 30, 2026
3. Brief profile, in case of appointment Not Applicable
4. Disclosure of relationships between
directors (in case of appointment of a
director).
Not Applicable
Additional Information in case of resignation of Independent Director
5. Letter
of
Resignation
along
with
detailed reason for resignation.
Enclosed as Annexure -
B
6. Names of listed entities in which the
resigning director holds directorships,
indicating the category of directorship
and membership of board committees, if
any.
Directorships in listed entities

Federal-Mogul Goetze (India) Limited

Sundrop Brands Limited
Committee Position(s) in listed entities

Federal-Mogul Goetze (India) Limited:
He
holds
membership
in
Nomination
and
Remuneration
Committee,
Corporate
Social
Responsibility
Committee,
Share
Transfer
Committee,
Audit
Committee
and
Risk
Management Committee. He holds chairmanship in
Stakeholders' Relationship Committee.

Sundrop Brands Limited:
He
holds
membership
in
Nomination
and
Remuneration
Committee,
Stakeholders'
Relationship
Committee,
Risk
Management
Committee and Corporate Social Responsibility
Committee. He holds chairmanship in Audit
Committee.
7. The independent director shall, along
with the detailed reasons, also provide a
confirmation that there are no other
material
reasons
other
than
those
provided.
CA
Rajesh Jain
has
confirmed that
there are no material
reasons for his
resignation other than those
mentioned
in his e-mail.

Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27 Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]

Subject:

Sub: Resignation from the directorship of Panacea Biotec Limited

From: Rajesh Jain< Sent: 30 March 2026 07:35 To:

Subject: Sub: Resignation from the directorship of Panacea Biotec Limited

March 30, 2026 To The Board of Directors Panacea Biotec Limited B-1 Extn. / G-3, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi - 110044

Sub: Resignation from the directorship of Panacea Biotec Limited

Dear Sir(s),

I am writing to formally communicate my decision to resign from the position of Independent Director of Panacea Biotec Limited ("Company"), effective from the close of business hours on 30th June, 2026.

My decision stems from my overall professional commitments and the increasing demands on time arising from the evolving regulatory and governance framework. In this context, I find that effective workload management on my part would not allow me to devote the requisite time, attention and diligence that a role of this magnitude now requires.

In the interest of maintaining the highest standards of corporate governance, I believe it is appropriate to step down from my position. Consequently, I will also be stepping down from all the Committees of the Board of Directors of the Company of which I am Chairman and/or Member including Audit Committee and Nomination and Remuneration Committee.

I confirm that there are no other material reasons other than those stated above.

I would like to express my sincere gratitude to my colleagues on the Board and the senior management team for their unwavering cooperation and support throughout my tenure. It has been a privilege to contribute to the Company's strategic initiatives during this period.

I request you to kindly take the same on record and arrange to file the necessary disclosures with the Stock Exchanges and Registrar of Companies in compliance with the applicable Laws.

I wish the Company continues to grow and achieve success in all its future endeavors.

Thanking You, Yours Faithfully,

CA Rajesh Jain Independent Director DIN: 10619014

Subject: Sub: Resignation from the directorship of Panacea Biotec Pharma Ltd

From: Rajesh Jain< ______ > Sent: Monday, March 30, 2026 7:34 AIVI To:

Subject: Sub: Resignation from the directorship of Panacea Biotec Pharma Ltd

March 30, 2026 To The Board of Directors Panacea Biotec Pharma Ltd B-1 Extn. I G-3, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi - 110044

Sub: Resignation from the directorship of Panacea Biotec Pharma Ltd

Dear Sir(s),

I am writing to formally communicate my decision to resign from the position of Independent Director of Panacea Biotec Pharma Ltd ("Company"), effective from the close of business hours on 30th June, 2026.

My decision stems from my overall professional commitments and the increasing demands on time arising from the evolving regulatory and governance framework. In this context, I find that effective workload management on my part would not allow me to devote the requisite time, attention and diligence that a role of this magnitude now requires.

In the interest of maintaining the highest standards of corporate governance, I believe it is appropriate to step down from my position. Consequently, I will also be stepping down from all the Committees of the Board of Directors of the Company of which I am Chairman and/or Member including Audit Committee and Nomination and Remuneration Committee.

I confirm that there are no other material reasons other than those stated above.

I would like to express my sincere gratitude to my colleagues on the Board and the senior management team for their unwavering cooperation and support throughout my tenure. It has been a privilege to contribute to the Company's strategic initiatives during this period.

I request you to kindly take the same on record and arrange to file the necessary disclosures with the Stock Exchanges and Registrar of Companies in compliance with the applicable Laws.

I wish the Company continues to grow and achieve success in all its future endeavors.

Thanking You, Yours Faithfully,

CA Rajesh Jain Independent Director DIN: 10619014